Xin Lang Cai Jing·2025-09-24 02:29Core Viewpoint - The stock of BeiGene has shown significant volatility, with a year-to-date increase of 92.45% but a recent decline in the last five trading days, indicating potential market fluctuations and investor sentiment shifts [2]. Group 1: Stock Performance - As of September 24, BeiGene's stock price reached 309.88 CNY per share, with a market capitalization of 477.43 billion CNY [1]. - The stock has experienced a 1.10% decline over the last five trading days, while it has increased by 25.96% over the past 20 days and 33.79% over the last 60 days [2]. - The company has appeared on the stock market's "龙虎榜" once this year, with the latest occurrence on September 2 [2]. Group 2: Financial Performance - For the first half of 2025, BeiGene reported a revenue of 17.518 billion CNY, reflecting a year-on-year growth of 46.03%, and a net profit attributable to shareholders of 450 million CNY, which is a 115.63% increase compared to the previous year [2]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for BeiGene was 23,300, a decrease of 3.90% from the previous period, with an average of 4,976 shares held per shareholder, an increase of 4.11% [2]. - Among the top ten circulating shareholders, notable changes include an increase in holdings by 中欧医疗健康混合A and a decrease in holdings by 万家优选 and 工银前沿医疗股票A [3].